Lung ultrasound for ILD in SSc/IIM would be great, no radiation and by the bedside - but a lot of skill required to interpret in reality. Maybe AI/computer vision can come to the rescue? Some nice models @StanfordRheum - will be watching this space! #ACR24 ABST1965 @RheumNow https://t.co/0uXBSVSE4c

"There's an app for that" but is it enough? US informatics national survey 2017-18: Rheum pts with digital health tools weren't any healthier living than those without (maybe helps exercise) It might be a conversation starter, but it's only an adjunct #ACR24 ABST1929 @RheumNow https://t.co/EZpSwm0zuP

Systemic polyarteritis nodosa looks creepily/scarily beautiful on PET/CT. Look at that Christmas tree! but sensitivity can be affected by pred, & isn't great even without (48%). By itself, a good rule in test, but not a good rule out test. #ACR24 ABST1962 @MayoClinic @RheumNow https://t.co/y28J6VKja4

Always looking for cancer/CV signals from JAKi in big observational datasets w extensive JAKi use nationwide 🇯🇵 claims data RA pts n=52k (JAKi n=4.3k) Cancer with JAKi vs TNFi: aHR 2.2 (esp lung, lymphoma) This is a problem. Watch these data. #ACR24 ABST1336 @RheumNow #ACRBest https://t.co/vsnT46De6T

Can you build systems that stop that ANA neg ENA pos anxiety? Plus $$? Lehigh Valley, Allentown, PA: lab would run ENA+dsDNA automatically, but only when ANA >1:80 (i.e. leave the ENA order to the lab) first voluntary, then compulsory it's possible! #ACR24 ABST1931 @RheumNow https://t.co/UQjWwve7DV

ANA neg, but ENA pos should we care about that result? PPV 5.5% here (similar to 6% prev @EricFMorand: https://t.co/Hyaued3rw2) and how many really needed the serology? Anxiety? Surely pos ENA w neg ANA might be more hassle than help. So what to do?⬇️ #ACR24 ABST1930 @RheumNow https://t.co/rE7RmgOGey

Should you worry about giving TNFi to RA pts after a cancer diagnosis? Medicare data with colorectal, lung, prostate Ca: TNFi pts survival no worse (numerically better) than csDMARDs Cancer pts deserve good RA treatment! #ACR24 ABST0202 Suarez-Almazor @MDAndersonNews @RheumNow https://t.co/w58MNqRt1T

Probably no surprise, but if you can navigate the digital world, it portends work for your rheum disease. all @MedUni_Wien rheum clinic pts did an eHealth survey high eHealth literacy did much better We can't leave digital stragglers behind! #ACR24 ABST1942 @Stiddyo @RheumNow https://t.co/c9IyPz6ujJ

Now we have GWAS, we are getting polygenic risk scores for RA, and we can see what disease risks cluster with RA risk. RA genetic risk clusters with risk for: type 1 diabetes thyroiditis multiple sclerosis What draws these diseases together? #ACR24 ABST1365 @RheumNow https://t.co/28gU1nBEUG

Upadacitinib in Behcet's disease - would be very much welcomed, and this open label 8 patient pilot from China is encouraging. We saw similar data for tofacitinib before @ARD_BMJ: https://t.co/YlAQVXpnTY JAKi (?generic) could be a fantastic option! #ACR24 ABST2515 @RheumNow https://t.co/65friNLUOK

Effective RA therapy is about more than just joints 🇪🇸 RA cohort TNFi for first 24w led to: Lean mass index i.e. muscle going up Fat mass index i.e. fat trending down Muscle & fat composition are important Systemic Rx can deliver systemic benefits #ACR24 ABST1348 @RheumNow https://t.co/mZjcHwxMgW